{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:40:53Z","timestamp":1761662453045},"reference-count":133,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.cld.2006.08.019","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T15:10:36Z","timestamp":1168441836000},"page":"881-900","source":"Crossref","is-referenced-by-count":5,"title":["New Therapies in Hepatitis C Virus and Chronic Liver Disease: Antifibrotics"],"prefix":"10.1016","volume":"10","author":[{"given":"Don C.","family":"Rockey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2006.08.019_bib1","unstructured":"Rockey DC, Friedman SL. Hepatic fibrosis. In: Boyer TD, Wright TL, Manns MP, editors. Zakim and Boyer's hepatology: a textbook of liver disease. 5th edition. Philadelphia: Saunders; 2006."},{"key":"10.1016\/j.cld.2006.08.019_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/jhep.2002.34734","article-title":"Burden of liver disease in the United States: summary of a workshop","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib3","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/hep.1840360710","article-title":"Hepatocellular carcinoma and hepatitis C in the United States","volume":"36","author":"El-Serag","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/jlts.2003.50073","article-title":"Projecting future complications of chronic hepatitis C in the United States","volume":"9","author":"Davis","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2006.08.019_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1535-6108(04)00058-3","article-title":"Focus on hepatocellular cancer","volume":"5","author":"Bruix","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cld.2006.08.019_bib6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C","volume":"34","author":"Poynard","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.08.019_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.276.5309.75","article-title":"Wound healing: aiming for perfect skin regeneration","volume":"276","author":"Martin","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cld.2006.08.019_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0074-7696(08)61986-5","article-title":"Cell biology of wound healing","volume":"169","author":"Schaffer","year":"1996","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.cld.2006.08.019_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/hep.1840190215","article-title":"Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: localization and association with progression of liver fibrosis","volume":"19","author":"Holstege","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib10","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1172\/JCI118304","article-title":"Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression","volume":"96","author":"Lee","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/hep.510270313","article-title":"Fibrogenic effect of oxidative stress on rat hepatic stellate cells","volume":"27","author":"Svegliati Baroni","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib12","unstructured":"Choy-Smith C, Sempkowski G, Rockey DC. Increased hepatic fibrosis in very young mice is associated with induction of liver natural killer cells. Hepatology 2001;34:394A."},{"key":"10.1016\/j.cld.2006.08.019_bib13","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1172\/JCI24798","article-title":"Attenuated liver fibrosis in the absence of B cells","volume":"115","author":"Novobrantseva","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2004.04.062","article-title":"Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes","volume":"127","author":"Safadi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.08.019_bib15","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.82.24.8681","article-title":"Hepatic lipocytes: the principal collagen-producing cells of normal rat liver","volume":"82","author":"Friedman","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cld.2006.08.019_bib16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI115089","article-title":"Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: alpha-smooth muscle actin is a marker of mesangial cell proliferation","volume":"87","author":"Johnson","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib17","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1073\/pnas.73.10.3719","article-title":"Vitamin A-containing lipocytes and formation of type III collagen in liver injury","volume":"73","author":"Kent","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cld.2006.08.019_bib18","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C","volume":"122","author":"Poynard","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.08.019_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1073\/pnas.73.2.539","article-title":"Increase in type I and type III collagens in human alcoholic liver cirrhosis","volume":"73","author":"Rojkind","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cld.2006.08.019_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2008-1040452","article-title":"Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins","volume":"10","author":"Schuppan","year":"1990","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2006.08.019_bib21","first-page":"1463","article-title":"Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells","volume":"148","author":"Gallai","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cld.2006.08.019_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.1840160131","article-title":"Biglycan and decorin gene expression in normal and fibrotic rat liver: cellular localization and regulatory factors","volume":"16","author":"Meyer","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0168-8278(90)90115-8","article-title":"Modulation of extracellular matrix components during dimethylnitrosamine-induced cirrhosis","volume":"11","author":"Jezequel","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.08.019_bib24","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1172\/JCI114886","article-title":"Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo","volume":"86","author":"Maher","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib25","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1083\/jcb.127.6.2037","article-title":"Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis","volume":"127","author":"Jarnagin","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cld.2006.08.019_bib26","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/hep.1840150526","article-title":"Localization and cellular source of the extracellular matrix protein tenascin in normal and fibrotic rat liver","volume":"15","author":"Van Eyken","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0074-7696(08)61977-4","article-title":"Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs","volume":"66","author":"Wake","year":"1980","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.cld.2006.08.019_bib28","doi-asserted-by":"crossref","first-page":"D793","DOI":"10.2741\/gressner","article-title":"Roles of TGF-beta in hepatic fibrosis","volume":"7","author":"Gressner","year":"2002","journal-title":"Front Biosci"},{"key":"10.1016\/j.cld.2006.08.019_bib29","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1172\/JCI114362","article-title":"Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium: direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors","volume":"84","author":"Friedman","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/hep.510250102","article-title":"The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide","volume":"25","author":"Rockey","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib31","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1172\/JCI116769","article-title":"Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo","volume":"92","author":"Rockey","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib32","doi-asserted-by":"crossref","first-page":"d1899","DOI":"10.2741\/marra","article-title":"Chemokines in liver inflammation and fibrosis","volume":"7","author":"Marra","year":"2002","journal-title":"Front Biosci"},{"key":"10.1016\/j.cld.2006.08.019_bib33","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1172\/JCI116753","article-title":"Cultured human liver fat-storing cells produce monocyte chemotactic protein-1: regulation by proinflammatory cytokines","volume":"92","author":"Marra","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib34","doi-asserted-by":"crossref","first-page":"C876","DOI":"10.1152\/ajpcell.1992.262.4.C876","article-title":"Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors","volume":"262","author":"Pinzani","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cld.2006.08.019_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2001-17554","article-title":"Cytokine receptors and signaling in hepatic stellate cells","volume":"21","author":"Pinzani","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2006.08.019_bib36","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1172\/JCI114270","article-title":"Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen","volume":"84","author":"Arthur","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-2001-17557","article-title":"Stellate cell behavior during resolution of liver injury","volume":"21","author":"Iredale","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2006.08.019_bib38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI115850","article-title":"Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1: implications for regulation of matrix degradation in liver","volume":"90","author":"Iredale","year":"1992","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib39","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.LAB.0000069036.63405.5C","article-title":"Apoptotic body engulfment by a human stellate cell line is profibrogenic","volume":"83","author":"Canbay","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/j.gastro.2003.11.018","article-title":"Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells","volume":"126","author":"Bataller","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.08.019_bib41","doi-asserted-by":"crossref","first-page":"11329","DOI":"10.1074\/jbc.M410161200","article-title":"Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells","volume":"280","author":"Mazzocca","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cld.2006.08.019_bib42","first-page":"193","article-title":"Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture","volume":"24","author":"Rockey","year":"1992","journal-title":"J Submicrosc Cytol Pathol"},{"key":"10.1016\/j.cld.2006.08.019_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/jhep.2003.50044","article-title":"Vascular mediators in the injured liver","volume":"37","author":"Rockey","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib44","first-page":"431","article-title":"Recent advances in pericyte biology: implications for health and disease","volume":"7","author":"Sims","year":"1991","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cld.2006.08.019_bib45","first-page":"1565","article-title":"Chronic ethanol consumption increases hepatic sinusoidal contractile response to endothelin-1 in the rat","volume":"22","author":"Bauer","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hep.510240137","article-title":"Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance","volume":"24","author":"Rockey","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib47","first-page":"209","article-title":"Contractility of myofibroblasts during experimental liver cirrhosis","volume":"12","author":"Irle","year":"1980","journal-title":"J Submicrosc Cytol"},{"key":"10.1016\/j.cld.2006.08.019_bib48","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1172\/JCI118055","article-title":"Cell-specific expression of transforming growth factor-beta in rat liver: evidence for autocrine regulation of hepatocyte proliferation","volume":"96","author":"Bissell","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib49","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0016-5085(94)90236-4","article-title":"Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells","volume":"107","author":"Marra","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.08.019_bib50","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.510300425","article-title":"Expression of connective tissue growth factor in experimental rat and human liver fibrosis","volume":"30","author":"Paradis","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib51","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1074\/jbc.274.5.3228","article-title":"Regulation of endothelin-1 synthesis by endothelin-converting enzyme-1 during wound healing","volume":"274","author":"Shao","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cld.2006.08.019_bib52","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","article-title":"Angiotensin II induces contraction and proliferation of human hepatic stellate cells","volume":"118","author":"Bataller","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.08.019_bib53","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib54","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj2870701","article-title":"Secretion of 72 kDa type IV collagenase\/gelatinase by cultured human lipocytes: analysis of gene expression, protein synthesis and proteinase activity","volume":"287","author":"Arthur","year":"1992","journal-title":"Biochem J"},{"key":"10.1016\/j.cld.2006.08.019_bib55","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840210328","article-title":"Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats","volume":"21","author":"Takahara","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib56","doi-asserted-by":"crossref","first-page":"G245","DOI":"10.1152\/ajpgi.2000.279.2.G245","article-title":"Metalloproteinases and their inhibitors in liver fibrosis","volume":"279","author":"Arthur","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cld.2006.08.019_bib57","first-page":"1647","article-title":"Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis","volume":"150","author":"Herbst","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cld.2006.08.019_bib58","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/jhep.2002.35625","article-title":"Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse","volume":"36","author":"Yoshiji","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib59","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/hep.510300432","article-title":"Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions","volume":"30","author":"Preaux","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib60","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI200112373","article-title":"DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells","volume":"108","author":"Olaso","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib61","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1074\/jbc.M310999200","article-title":"Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen","volume":"279","author":"Han","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cld.2006.08.019_bib62","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.12.1.463","article-title":"Focal adhesions, contractility, and signaling","volume":"12","author":"Burridge","year":"1996","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.cld.2006.08.019_bib63","doi-asserted-by":"crossref","first-page":"30911","DOI":"10.1074\/jbc.272.49.30911","article-title":"The role of alpha1beta1 integrin in wound contraction: a quantitative analysis of liver myofibroblasts in vivo and in primary culture","volume":"272","author":"Racine-Samson","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cld.2006.08.019_bib64","doi-asserted-by":"crossref","first-page":"23996","DOI":"10.1074\/jbc.M311668200","article-title":"Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells","volume":"279","author":"Zhou","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cld.2006.08.019_bib65","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hep.510230538","article-title":"Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis","volume":"23","author":"Baroni","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib66","first-page":"660","article-title":"Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis","volume":"42","author":"Rockey","year":"1994","journal-title":"J Investig Med"},{"key":"10.1016\/j.cld.2006.08.019_bib67","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","article-title":"Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners","volume":"130","author":"Radaeva","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.08.019_bib68","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1073\/pnas.94.20.10663","article-title":"Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses","volume":"94","author":"Shi","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cld.2006.08.019_bib69","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2006.08.019_bib70","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1002\/hep.21046","article-title":"Noninvasive measures of liver fibrosis","volume":"43","author":"Rockey","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib71","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1023\/A:1026601904609","article-title":"Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment","volume":"43","author":"Dufour","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2006.08.019_bib72","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"348","author":"Marcellin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2006.08.019_bib73","doi-asserted-by":"crossref","first-page":"981","DOI":"10.7326\/0003-4819-127-11-199712010-00006","article-title":"Reversibility of hepatic fibrosis in autoimmune hepatitis","volume":"127","author":"Dufour","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2006.08.019_bib74","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2006.08.019_bib75","first-page":"183","article-title":"Cirrhosis of the liver: a reversible disease?","volume":"14","author":"Perez-Tamayo","year":"1979","journal-title":"Pathol Annu"},{"key":"10.1016\/j.cld.2006.08.019_bib76","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM200102083440604","article-title":"Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct","volume":"344","author":"Hammel","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2006.08.019_bib77","first-page":"109","article-title":"Effects of colchicine and colchiceine in a biochemical model of liver injury and fibrosis","volume":"29","author":"Rodriguez","year":"1998","journal-title":"Arch Med Res"},{"key":"10.1016\/j.cld.2006.08.019_bib78","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198612043152304","article-title":"A prospective trial of colchicine for primary biliary cirrhosis","volume":"315","author":"Kaplan","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2006.08.019_bib79","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM198806303182602","article-title":"Colchicine in the treatment of cirrhosis of the liver","volume":"318","author":"Kershenobich","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2006.08.019_bib80","doi-asserted-by":"crossref","unstructured":"Morgan TR WD, Nemchausky B, Schiff ER, et al. Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival. Gastroenterology 2005;128:882.","DOI":"10.1053\/j.gastro.2005.01.057"},{"key":"10.1016\/j.cld.2006.08.019_bib81","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1034\/j.1600-0676.2001.021002129.x","article-title":"Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis","volume":"21","author":"Rambaldi","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.cld.2006.08.019_bib82","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/01.ALC.0000093743.03049.80","article-title":"II. Veterans Affairs Cooperative Study of Polyenylphosphatidylcholine in Alcoholic Liver Disease","volume":"27","author":"Lieber","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2006.08.019_bib83","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/hep.510280620","article-title":"Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis","volume":"28","author":"Thompson","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib84","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1053\/jhep.2003.50427","article-title":"Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect","volume":"38","author":"Nelson","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib85","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.1840160325","article-title":"Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma","volume":"16","author":"Rockey","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib86","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1073\/pnas.91.2.614","article-title":"Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver","volume":"91","author":"Toyonaga","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cld.2006.08.019_bib87","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2893.2005.00689.x","article-title":"Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection","volume":"13","author":"Muir","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cld.2006.08.019_bib88","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/hep.510260316","article-title":"Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats","volume":"26","author":"Boigk","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib89","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0168-8278(01)00148-9","article-title":"Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1","volume":"35","author":"Jia","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.08.019_bib90","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00004836-200310000-00013","article-title":"Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons","volume":"37","author":"Lieber","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cld.2006.08.019_bib91","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0168-8278(89)90083-4","article-title":"Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver","volume":"9","author":"Ferenci","year":"1989","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.08.019_bib92","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0168-8278(98)80285-7","article-title":"Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial","volume":"28","author":"Pares","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.08.019_bib93","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2362.1997.910615.x","article-title":"Effect of colchiceine and ursodeoxycholic acid on hepatocyte and erythrocyte membranes and liver histology in experimentally induced carbon tetrachloride cirrhosis in rats","volume":"27","author":"Nava-Ocampo","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cld.2006.08.019_bib94","first-page":"759","article-title":"A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"22","author":"Combes","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib95","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.510290444","article-title":"Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression","volume":"29","author":"Degott","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib96","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2006.08.019_bib97","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hep.510250303","article-title":"Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis","volume":"25","author":"Jacquemin","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib98","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.510270126","article-title":"A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease","volume":"27","author":"Lindblad","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib99","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/hep.20092","article-title":"Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial","volume":"39","author":"Lindor","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib100","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/hep.510290603","article-title":"Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group","volume":"29","author":"Poupon","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib101","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(03)00192-2","article-title":"Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis","volume":"39","author":"Poupon","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.08.019_bib102","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/07853899409148349","article-title":"Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis","volume":"26","author":"Stiehl","year":"1994","journal-title":"Ann Med"},{"key":"10.1016\/j.cld.2006.08.019_bib103","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1572-0241.2004.04047.x","article-title":"Prolonged follow-up of patients in the US multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis","volume":"99","author":"Combes","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2006.08.019_bib104","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/jhep.2003.50420","article-title":"Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone","volume":"38","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib105","first-page":"G116","article-title":"Effect of vitamin E supplementation on hepatic fibrogenesis in chronic dietary iron overload","volume":"272","author":"Brown","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cld.2006.08.019_bib106","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1046\/j.1365-2036.2001.01083.x","article-title":"Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study","volume":"15","author":"Hasegawa","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2006.08.019_bib107","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/gast.1997.v113.pm9322499","article-title":"A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C","volume":"113","author":"Houglum","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.08.019_bib108","doi-asserted-by":"crossref","first-page":"264A","DOI":"10.1016\/S0270-9139(03)80268-9","article-title":"A randomized placebo controlled trial of vitamin E in alcoholic hepatitis","volume":"38","author":"Mezey","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib109","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0168-8278(02)80041-1","article-title":"A trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"36","author":"Stewart","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.08.019_bib110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0168-8278(05)80043-1","article-title":"Anonymous. The results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosis: a European multicentre study group","volume":"17","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.08.019_bib111","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0232-1513(11)80156-8","article-title":"The effect of D-penicillamine on CCl4-induced experimental liver cirrhosis","volume":"43","author":"Schaff","year":"1991","journal-title":"Exp Pathol"},{"key":"10.1016\/j.cld.2006.08.019_bib112","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.1840050613","article-title":"A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis","volume":"5","author":"Bodenheimer","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib113","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","article-title":"Trial of penicillamine in advanced primary biliary cirrhosis","volume":"312","author":"Dickson","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2006.08.019_bib114","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2036.2004.01819.x","article-title":"Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?","volume":"19","author":"Aithal","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2006.08.019_bib115","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-126-9-199705010-00002","article-title":"Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment","volume":"126","author":"Kaplan","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2006.08.019_bib116","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep.20897","article-title":"Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis","volume":"42","author":"Combes","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib117","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0741-8329(02)00226-4","article-title":"Role of abnormal methionine metabolism in alcoholic liver injury","volume":"27","author":"Lu","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.cld.2006.08.019_bib118","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","article-title":"S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial","volume":"30","author":"Mato","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.08.019_bib119","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1034\/j.1600-0676.2001.210606.x","article-title":"Meta-analysis of propylthiouracil for alcoholic liver disease: a Cochrane Hepato-Biliary Group Review","volume":"21","author":"Rambaldi","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.cld.2006.08.019_bib120","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/j.1572-0241.2002.05826.x","article-title":"Anabolic-androgenic steroids for alcoholic liver disease: a Cochrane review","volume":"97","author":"Rambaldi","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2006.08.019_bib121","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.08.019_bib122","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","article-title":"A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis","volume":"99","author":"Menon","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2006.08.019_bib123","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.08.019_bib124","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","article-title":"Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis","volume":"38","author":"Tilg","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.08.019_bib125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1542-3565(04)00445-8","article-title":"Antifibrotic therapy in chronic liver disease","volume":"3","author":"Rockey","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2006.08.019_bib126","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm0496-418","article-title":"Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney","volume":"2","author":"Isaka","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.cld.2006.08.019_bib127","doi-asserted-by":"crossref","first-page":"12719","DOI":"10.1073\/pnas.96.22.12719","article-title":"In vivo inhibition of rat stellate cell activation by soluble TGF beta type II receptor: a potential new therapy for hepatic fibrosis","volume":"96","author":"George","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cld.2006.08.019_bib128","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/jhep.2002.32673","article-title":"Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy","volume":"35","author":"Yata","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.08.019_bib129","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0168-8278(02)00245-3","article-title":"Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production","volume":"37","author":"Di Sario","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.08.019_bib130","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/gast.2000.9365","article-title":"Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells","volume":"119","author":"Marra","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.08.019_bib131","doi-asserted-by":"crossref","first-page":"35715","DOI":"10.1074\/jbc.M006577200","article-title":"Peroxisome proliferator-activated receptors and hepatic stellate cell activation","volume":"275","author":"Miyahara","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cld.2006.08.019_bib132","doi-asserted-by":"crossref","first-page":"G902","DOI":"10.1152\/ajpgi.00124.2006","article-title":"Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis","volume":"291","author":"Yang","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cld.2006.08.019_bib133","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/jhep.2001.21408","article-title":"Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats","volume":"33","author":"Bruck","year":"2001","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326106000353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326106000353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T13:43:20Z","timestamp":1628343800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326106000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":133,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1089326106000353"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2006.08.019","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}